AR120892A1 - PROGRANULIN VARIANTS - Google Patents

PROGRANULIN VARIANTS

Info

Publication number
AR120892A1
AR120892A1 ARP200103636A ARP200103636A AR120892A1 AR 120892 A1 AR120892 A1 AR 120892A1 AR P200103636 A ARP200103636 A AR P200103636A AR P200103636 A ARP200103636 A AR P200103636A AR 120892 A1 AR120892 A1 AR 120892A1
Authority
AR
Argentina
Prior art keywords
progranulin
variants
seq
variant
sequence
Prior art date
Application number
ARP200103636A
Other languages
Spanish (es)
Inventor
Gerald Maxwell Cherf
Gunasekaran Kannan
Katrina W Lexa
Ray L Y Low
Rachel Prorok
Ankita Srivastava
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Publication of AR120892A1 publication Critical patent/AR120892A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan en la presente variantes de progranulina y proteínas de fusión que comprenden una variante de progranulina y un polipéptido Fc. También se proporcionan en la presente métodos para el uso de dichas proteínas para el tratamiento de trastornos asociados con la progranulina (por ejemplo, una enfermedad neurodegenerativa, tal como demencia frontotemporal (FTD)). Una variante de progranulina que comprende una secuencia que tiene al menos 90% de identidad con la SEQ ID Nº 2 y una secuencia definida mediante X¹X²X³ en las posiciones correspondientes a los residuos 574 a 576 de la SEQ ID Nº 2, donde cada uno de X¹, X² y X³ es independientemente un aminoácido y juntos no son QLL.Progranulin variants and fusion proteins comprising a progranulin variant and an Fc polypeptide are provided herein. Also provided herein are methods of using such proteins for the treatment of progranulin-associated disorders (eg, a neurodegenerative disease, such as frontotemporal dementia (FTD)). A progranulin variant comprising a sequence having at least 90% identity to SEQ ID No. 2 and a sequence defined by X¹X²X³ at positions corresponding to residues 574 to 576 of SEQ ID No. 2, where each of X¹ , X² and X³ is independently an amino acid and together they are not QLL.

ARP200103636A 2019-12-23 2020-12-23 PROGRANULIN VARIANTS AR120892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962953099P 2019-12-23 2019-12-23

Publications (1)

Publication Number Publication Date
AR120892A1 true AR120892A1 (en) 2022-03-30

Family

ID=80995006

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103636A AR120892A1 (en) 2019-12-23 2020-12-23 PROGRANULIN VARIANTS

Country Status (1)

Country Link
AR (1) AR120892A1 (en)

Similar Documents

Publication Publication Date Title
ECSP20081591A (en) FUSION PROTEINS INCLUDING PROGRANULIN
CO2022008648A2 (en) Progranulin variants
ES2563646T3 (en) Compositions and methods related to protein A (SpA) variants
IL288541B (en) Vaccine against rsv
PH12018502361A1 (en) Gdf15 fusion proteins and uses thereof
BR112018068189A2 (en) inducible binding proteins and methods of use
AR107290A1 (en) PEPTIDE ANTIBODIES b AMILOID ANTI-N3pGlu AND USES OF THE SAME
ES2694667T3 (en) Method for producing oxalate oxidases having optical activity near physiological pH and use of such recombinant oxalate oxidases in the treatment of oxalate-related diseases
CU20170112A7 (en) VARIOUS POLYPEPTIDES DIVIDING TOXINS FROM FUSARIUM, ADDITIVE CONTAINING THESE VARIATIONS AND THEIR USE, AS WELL AS PROCEDURES FOR DIVISION OF TOXINS FROM FUSARIUM
CL2023001433A1 (en) il-2 mutein; fusion protein; nucleic acid; vector; host cell; methods; use
CO2020013699A2 (en) Compositions aav, methods of manufacture and methods of use
CL2020002561A1 (en) Compositions and methods for the treatment of macular dystrophy
PE20220429A1 (en) VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH HIGHER EXPRESSION FOR GENOTHERAPY OF HEMOPHILIA A
AR095076A1 (en) PEPTIDES AND COMPOSITIONS FOR THE TREATMENT OF ARTICULAR DAMAGE
MX2020006586A (en) Methods for enhanced removal of impurities during protein a chromatography.
CR20170507A (en) VARIOUS FUSIONS III OF THE EPIDERMAL-MESOTHELINE GROWTH FACTOR RECEPTOR AND METHODS TO USE THE SAME.
CO2019012204A2 (en) Anti-jagged1 antigen-binding proteins
AR120892A1 (en) PROGRANULIN VARIANTS
RU2016135003A (en) NEW TYPES OF TREATMENT
ECSP22049014A (en) PROGRANULIN VARIANTS
PE20190967A1 (en) MODIFIED ISOLATED STREPTOMYCES FUNGICIDICUS AND ITS USE
WO2021003413A3 (en) Self-assembling circular tandem repeat proteins with increased stability
PE20190104A1 (en) ANTIGENS AND ANTIBODIES OF CHAGAS AND COMPOSITIONS, METHODS AND USES OF THE SAME
AR115565A1 (en) FUSION PROTEINS INCLUDING PROGRANULIN
EA202190062A1 (en) FUSION PROTEINS CONTAINING PROGRANULIN